ProShare Advisors LLC Has $405,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)
ProShare Advisors LLC Has $405,000 Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)
ProShare Advisors LLC lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 10.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,255 shares of the company's stock after selling 2,097 shares during the period. ProShare Advisors LLC's holdings in Pediatrix Medical Group were worth $405,000 as of its most recent SEC filing.
ProShare Advisors LLC在提交給美國證券交易委員會(Securities&Exchange Commission)的最新Form 13F文件中稱，該公司在第一季度減持了Pediatrix Medical Group，Inc.(紐約證券交易所代碼：MD-GET)的股票10.8%。該基金在此期間出售了2,097股後，持有該公司17,255股股票。截至最近提交給美國證券交易委員會的文件，ProShare Advisors LLC持有的兒科醫療集團股份價值40.5萬美元。
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Brandes Investment Partners LP grew its holdings in Pediatrix Medical Group by 17.5% during the first quarter. Brandes Investment Partners LP now owns 137,207 shares of the company's stock valued at $3,222,000 after purchasing an additional 20,462 shares during the last quarter. Boston Partners grew its stake in shares of Pediatrix Medical Group by 72.3% in the first quarter. Boston Partners now owns 22,194 shares of the company's stock worth $521,000 after acquiring an additional 9,311 shares during the last quarter. Campbell & CO Investment Adviser LLC acquired a new stake in shares of Pediatrix Medical Group in the first quarter worth $421,000. Swiss National Bank grew its stake in shares of Pediatrix Medical Group by 7.4% in the first quarter. Swiss National Bank now owns 184,000 shares of the company's stock worth $4,320,000 after acquiring an additional 12,600 shares during the last quarter. Finally, Duality Advisers LP acquired a new stake in shares of Pediatrix Medical Group in the first quarter worth $622,000. Institutional investors and hedge funds own 95.98% of the company's stock.
其他幾家對衝基金和其他機構投資者最近也增持或減持了該股。Brandes Investment Partners LP在第一季度增持了17.5%的Pediatrix Medical Group股份。Brandes Investment Partners LP在上個季度額外購買了20,462股後，現在擁有137,207股該公司股票，價值3,222,000美元。波士頓合夥公司在第一季度增持了Pediatrix Medical Group的股份72.3%。波士頓合夥公司在上個季度增持了9,311股後，現在持有22,194股該公司股票，價值521,000美元。Campbell&CO Investment Adviser LLC在第一季度收購了Pediatrix Medical Group價值42.1萬美元的新股。瑞士國家銀行在第一季度增持了Pediatrix Medical Group的股份7.4%。瑞士國家銀行目前持有18.4萬股該公司股票，價值432萬美元，在上個季度增持了1.26萬股。最後，Duality Advisers LP在第一季度收購了Pediatrix Medical Group價值622,000美元的新股份。機構投資者和對衝基金持有該公司95.98%的股票。
Analyst Upgrades and Downgrades
分析師升級和下調評級
Several equities research analysts have recently issued reports on MD shares. BMO Capital Markets lowered their price objective on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a research note on Wednesday, August 10th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a research note on Tuesday, May 10th. Finally, Credit Suisse Group lowered their price objective on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Thursday, August 11th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $24.67.
幾位股票研究分析師最近發佈了關於MD股票的報告。BMO Capital Markets在8月10日(星期三)的一份研究報告中將Pediatrix Medical Group的股票目標價從25.00美元下調至23.00美元，並對該股設定了“市場表現”評級。德意志銀行Aktiengesellschaft在5月10日星期二的一份研究報告中將Pediatrix Medical Group的股票目標價從24.00美元下調至16.00美元。最後，瑞士信貸集團在8月11日(星期四)的一份研究報告中將Pediatrix Medical Group的股票目標價從30.00美元下調至28.00美元，並對該股設定了“跑贏大盤”的評級。四名分析師對該股的評級為持有，一名分析師對該股的評級為買入。根據MarketBeat.com的數據，該股目前的共識評級為持有，共識目標價為24.67美元。
Pediatrix Medical Group Stock Down 1.4 %
兒科醫療集團股價下跌1.4%
Pediatrix Medical Group (NYSE:MD – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. The firm had revenue of $486.00 million for the quarter, compared to the consensus estimate of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The business's revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.36 earnings per share. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.71 EPS for the current year.
Pediatrix醫療集團(紐約證券交易所代碼：MD-GET評級)最近一次公佈季度收益結果是在8月4日星期四。該公司公佈本季度每股收益為0.47美元，比分析師普遍預期的0.43美元高出0.04美元。該公司本季度營收為4.86億美元，而市場普遍預期為4.9154億美元。兒科醫療集團的淨利潤率為4.30%，股本回報率為16.15%。與去年同期相比，該業務的收入增長了2.7%。去年同期，該公司每股收益為0.36美元。分析師平均預計，Pediatrix Medical Group，Inc.本年度每股收益為1.71美元。
Pediatrix Medical Group Company Profile
兒科醫療集團公司簡介
(Get Rating)
(獲取評級)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
兒科醫療集團及其子公司在美國和波多黎各提供新生兒、母嬰、兒科心臟病和其他兒科專科護理服務。它通過新生兒內科專科醫生、新生兒護士執業醫生和其他兒科臨牀醫生，為醫院特定單元內早產或有併發症的嬰兒提供新生兒護理服務。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免費獲取StockNews.com關於兒科醫療集團(MD)的研究報告
- 隨着管理層重組，股市能否迅速反彈？
- MarketBeat：回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
- 露露檸檬將飆升至9月
- 耐克股票會被超賣，但仍被高估嗎？
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受《兒科醫療集團日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pediatrix Medical Group和相關公司的最新新聞和分析師評級的每日簡要摘要。